Lord, Abbett & Co. LLC Neurocrine Biosciences Inc Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	SELL	$130.86 - $143.19 $46.7 Million - $51.1 Million	-356,801 Reduced 91.2%	34,443 $4.74 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $46.7 Million - $51.1 Million	-356,801 Reduced 91.2%	34,443 $4.74 Million
Q1 2024 Oct 07, 2024	BUY	$130.4 - $143.74 $44.9 Million - $49.5 Million	344,263 Added 732.77%	391,244 $54 Million
Q1 2024 May 09, 2024	BUY	$130.4 - $143.74 $44.9 Million - $49.5 Million	344,263 Added 732.77%	391,244 $54 Million
Q4 2023 Oct 07, 2024	BUY	$106.07 - $132.76 $4.71 Million - $5.89 Million	44,383 Added 1708.35%	46,981 $6.19 Million
Q4 2023 Feb 12, 2024	BUY	$106.07 - $132.76 $4.98 Million - $6.24 Million	46,981 New	46,981 $6.19 Million
Q4 2022 Oct 07, 2024	SELL	$106.72 - $127.06 $3.4 Million - $4.05 Million	-31,845 Reduced 92.46%	2,598 $311,000
Q4 2022 Feb 10, 2023	BUY	$106.72 - $127.06 $277,258 - $330,101	2,598 New	2,598 $311,000
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $5.71 Million - $8.76 Million	-67,163 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$75.11 - $113.76 $1.2 Million - $1.81 Million	-15,943 Reduced 19.18%	67,163 $5.81 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $985,614 - $1.35 Million	-11,355 Reduced 12.02%	83,106 $8.93 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $13,159 - $15,935	157 Added 0.17%	94,461 $8.51 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $2.64 Million - $3.33 Million	36,477 Added 63.08%	94,304 $7.96 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $100,014 - $132,077	1,443 Added 2.56%	57,827 $5.1 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $206,258 - $375,442	-3,019 Reduced 5.08%	56,384 $4.03 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $5.87 Million - $7.48 Million	59,403 New	59,403 $7.3 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account